There was a 2.1‐fold higher hazard for cognitive impairment in the MBI‐psychosis group relative to the No Psychosis group in APOE ε4 non‐carriers, but this did not reach statistical significance (95% CI: 1–4.4, p = 0.05). The gene discussed is APOE; the disease is psychotic disorder.